Connect with Polish Suppliers
Contact: info@b2bpoland.com

Medical Devices

  1. Home
  2. Companies
  3. Medical Devices

Why Source Medical Devices from Poland?

Poland's medical device manufacturing sector generates approximately €2.3 billion in export revenues annually, with 750+ certified manufacturers serving hospitals, distributors, and healthcare procurement agencies across 80+ countries. Polish medtech companies combine rigorous regulatory compliance—with 91% of export-oriented manufacturers holding ISO 13485:2016 certification and full EU MDR (Regulation 2017/745) readiness—alongside manufacturing cost structures 35-50% below equivalent German or Dutch production, Central European logistics advantages enabling 1-4 day delivery to all major EU markets, and deep engineering capabilities across diagnostic equipment, surgical instruments, rehabilitation devices, dental products, and single-use consumables.

ISO 13485:2016 & EU MDR 2017/745
35-50% cost savings vs Germany
1-4 day delivery to EU markets
Download Sourcing Guide Join as Polish Manufacturer

Polish Medical Device Market Overview

Understanding Poland's medtech manufacturing sector and export capabilities

Poland's medical device industry has grown into a major European manufacturing base, generating approximately €2.3 billion in export revenues in 2025 from 750+ ISO 13485:2016-certified manufacturers employing roughly 38,000 specialists across production, R&D, regulatory affairs, and quality assurance. The sector benefits from a strong engineering tradition, proximity to major healthcare procurement markets in Germany, France, UK and the Nordics, full compliance with EU MDR 2017/745 and EU IVDR 2017/746, and manufacturing cost structures that remain 35-50% below comparable Western European producers—making Poland the preferred OEM and contract manufacturing partner for European distributors, hospital group procurement organisations (GPOs), and global medtech OEMs seeking nearshore production with established CE-marking infrastructure.

Product Segment Export Revenue (€M) Manufacturers Export Share Key Applications / Markets
Surgical Instruments & Tools €420 185 82% General surgery, laparoscopy, orthopaedics; DE, FR, UK
Diagnostic Equipment & Imaging €390 78 76% Point-of-care, ultrasound accessories, lab analysers
Rehabilitation & Orthopaedic Devices €310 112 74% Physiotherapy, orthotics, prosthetics, mobility aids
Hospital Furniture & Patient Care €295 98 71% Medical beds, OR tables, trolleys, patient lifts
Wound Care & Single-Use Devices €285 130 80% Sterile dressings, IV sets, sutures, gloves, catheters
Dental Equipment & Consumables €220 142 79% Dental units, implants, handpieces, composite materials
In-Vitro Diagnostics (IVD) €230 62 73% Reagents, rapid test kits, biochemical analysers
Healthcare IT & Medical Software (SaMD) €150 88 85% Class I SaMD, HIS/LIS systems, telemedicine platforms
TOTAL €2,300 ~895* ~78% —

*Total manufacturer count reflects export-active firms; some companies operate across multiple segments. Total domestic market including imports estimated at €4.8B. Source: OIGWM (Ogólnopolska Izba Gospodarcza Wyrobów Medycznych), GUS, PAIH Polish Medtech Sector Report 2025. Data: calendar year 2025.

Manufacturing Cost Competitiveness: Poland vs Western Europe

Polish medical device manufacturers maintain price competitiveness of 35-50% versus German and Dutch counterparts across all major product categories while meeting identical regulatory requirements (EU MDR 2017/745, ISO 13485:2016) and CE marking obligations. This cost advantage derives from lower manufacturing labour costs (average production worker wage €1,200-€1,800/month in Poland vs €3,200-€4,500/month in Germany), lower industrial real estate costs, and competitive energy tariffs—while quality infrastructure, metrology capabilities, clean-room manufacturing environments, and ERP/MES systems deployed by leading Polish manufacturers are indistinguishable from Western European peers. Total landed cost savings to European buyers typically range 28-42% after factoring freight from Poland, as logistics proximity (500-800 km to core German, Austrian and Dutch markets) keeps transport cost differentials minimal relative to the manufacturing savings achieved.

Product / Service Type Poland (€) Germany Netherlands Cost Saving
Basic surgical instrument set (10 pcs, SS316L) €85–€120 €155–€210 €160–€220 -44% to -46%
Hospital bed (electric, Class I, IEC 60601-2-52) €1,400–€2,200 €2,600–€4,000 €2,700–€4,200 -46% to -48%
Sterile single-use catheter (urinary, Foley, per unit) €0.38–€0.62 €0.75–€1.10 €0.78–€1.15 -44% to -46%
Orthopaedic rehabilitation chair (Class I) €380–€580 €700–€1,050 €720–€1,080 -45% to -47%
Dental handpiece (turbine, Class IIa) €95–€145 €190–€280 €195–€290 -49% to -50%
Contract sterilisation service (EtO, per pallet) €280–€420 €520–€780 €540–€800 -46% to -48%
Rapid diagnostic test kit (IVD, per 100 tests) €38–€65 €72–€120 €75–€125 -47% to -48%
IV infusion set (sterile, single-use, per unit) €0.28–€0.45 €0.55–€0.85 €0.57–€0.90 -49% to -50%
Medical-grade wound dressing (10x10cm, per 50 pcs) €14–€22 €26–€40 €27–€42 -46% to -48%
OEM contract manufacturing setup fee (Class IIa line) €18,000–€35,000 €38,000–€72,000 €40,000–€75,000 -51% to -54%

Prices represent typical ex-works quotations from Polish manufacturers to international B2B buyers, Q4 2025 market conditions. All products subject to applicable EU MDR/IVDR and ISO 13485:2016 quality requirements. CE marking, Notified Body fees, and regulatory documentation not included in unit prices. MOQ, packaging, and labelling specifications affect final pricing. German and Dutch prices sourced from published distributor catalogues and procurement benchmarks (KZBV, DKG, GHX Europe). Individual quotations may vary.

INDUSTRY INTELLIGENCE

Polish Medical Devices Insights

Essential procurement and market intelligence for international medtech buyers and distributors

Market Report 2026

Polish Medical Devices Market Guide 2026

Comprehensive analysis of Poland's €2.3B medical device export sector: manufacturing capabilities by segment, technology hubs (Warsaw, Wrocław, Kraków), pricing benchmarks, ISO 13485 / EU MDR compliance landscape, and procurement best practices for international buyers.

  • Market structure & segment analysis
  • Cost benchmarks vs Germany & Netherlands
  • EU MDR compliance & ISO 13485 verification
Read Full Report
Product Segment

Surgical Instruments & Diagnostic Equipment from Poland

Poland manufactures precision surgical instruments and diagnostic equipment for Class I–III applications, with ISO 13485:2016-certified production lines, CE marking, and established OEM supply relationships with major European hospital procurement networks.

Surgical Instruments Diagnostics OEM Supply

Standards: ISO 13485:2016, CE marking, EU MDR 2017/745

View Products
Buyer's Guide

Sourcing Medical Devices from Poland: Complete Procurement Guide

Practical framework for procurement managers, hospital buyers, and distributors: ISO 13485 vendor qualification, EU MDR Notified Body verification, contract structures, quality agreements (QAA), incoming inspection protocols, and intellectual property safeguards.

  • Vendor qualification checklist
  • Quality Agreement (QAA) structure
  • EU MDR & CE marking verification
Download Guide
Coming Soon

Verified Medical Device Supplier Directory

We are onboarding 300+ pre-vetted Polish medtech manufacturers. Get early access to our curated database with ISO 13485 status, product classifications (Class I/IIa/IIb/III), CE certificates, and direct contact details.

  • ISO 13485 & EU MDR verification
  • Device classification & CE certificates
  • Direct manufacturer contacts
Get Early Access

Delivery Times & Logistics to Key EU Markets

Polish manufacturers benefit from central European location enabling competitive freight costs and short lead times

Destination Distance from Warsaw Road Freight (days) Air Freight (days) Typical Freight Cost (per pallet) Notes
Germany (Berlin/Frankfurt) 520–810 km 1–2 Next day €90–€160 Most common export corridor; daily departures
Austria / Switzerland 620–950 km 2 Next day €110–€185 Strong hospital procurement market
Netherlands / Belgium 1,180–1,330 km 2–3 Next day €140–€220 Major European distribution hub market
France 1,450–1,800 km 3 Next day €155–€245 Growing Polish medtech export destination
United Kingdom 1,700–2,100 km 3–4 1–2 days €185–€320 UKCA marking required post-Brexit; customs clearance
Scandinavia (SE/NO/DK) 780–1,500 km 2–3 Next day €120–€210 High per-capita healthcare spend; growing buyer segment
Italy / Spain 1,400–2,800 km 3–4 1–2 days €165–€290 Large public hospital procurement volumes

Freight times reflect standard groupage/LTL road transport from major Polish manufacturing centres (Warsaw, Wrocław, Kraków, Łódź). Sterile and temperature-controlled shipments (Class IIb/III devices, cold-chain IVD reagents) may require specialised GDP-compliant carriers at premium rates. Express road freight available to Germany/Austria within 24 hours. All EU shipments benefit from customs-free Single Market movement.

Typical OEM / Contract Supply Engagement Timeline

From initial inquiry to first commercial shipment for a Class IIa device programme

1
Technical Qualification

Weeks 1–3

  • RFQ / technical brief submission
  • ISO 13485 certificate verification
  • Facility audit (remote or on-site)
  • Sample prototypes / first articles
2
Regulatory & QA Alignment

Weeks 3–8

  • Quality Agreement (QAA) negotiation
  • Technical File / DoC review
  • Notified Body coordination (if applicable)
  • Labelling & IFU localisation
3
Contract & Tooling

Weeks 6–14

  • Supply agreement & pricing terms
  • Tooling / mould setup (if required)
  • Validation batches (IQ/OQ/PQ)
  • Approved Supplier List registration
4
Serial Production

From Week 12+

  • First commercial delivery
  • Incoming inspection / CoC review
  • CAPA system activated
  • Annual supplier audit schedule
Total Time to First Commercial Shipment: 12–20 weeks typical

Timeline assumes Class IIa device with existing CE marking. Class III devices and IVDs requiring Notified Body involvement add 6–18 months for initial CE certification. Re-labelling of existing CE-marked products under private label (Article 16 MDR) can be achieved in 4–8 weeks.

Quality Standards & Regulatory Compliance Framework

Mandatory and widely adopted certifications among Polish medical device exporters

Standard / Regulation Adoption Rate* Scope & Applicability Verification Method
ISO 13485:2016
Medical Devices QMS		 91% Quality management system for design, production, and post-market surveillance of medical devices. Mandatory for all EU MDR-compliant manufacturers. EOTC / BSI / TÜV certificate registry. Verify certificate scope, expiry, and Notified Body number at ec.europa.eu/growth/tools-databases/nando/
EU MDR 2017/745
Medical Device Regulation		 88% EU regulatory framework for placing medical devices on the European market. Replaces MDD 93/42/EEC. Applies to all devices sold in the EU/EEA. EUDAMED database (eudamed.ec.europa.eu) for manufacturer/device registration. CE Declaration of Conformity review. Notified Body certificate (Class IIa/IIb/III).
EU IVDR 2017/746
In Vitro Diagnostic Regulation		 74% EU regulatory framework for in vitro diagnostic medical devices. Full application from May 2025. More stringent classification vs previous IVDD 98/79/EC. EUDAMED device registration. Performance evaluation documentation. Common Specifications compliance for Class C/D IVDs.
ISO 14971:2019
Risk Management		 89% Risk management processes throughout device lifecycle. Harmonised standard under EU MDR/IVDR. Required as part of Technical File. Review of Risk Management File during supplier audit. Confirm harmonised standard in DoC.
IEC 62304:2006+AMD1
Medical Device Software		 68% Software lifecycle processes for medical device software and Software as a Medical Device (SaMD). Applicable to Class I–III software-driven devices. Software Bill of Materials (SBOM), verification & validation records. Confirm in Technical File.
IEC 60601-1 (series)
Electrical Safety, Medical		 72% Safety and performance requirements for electrical medical equipment. Harmonised standard. Essential for powered diagnostic, surgical, and monitoring devices. Test reports from accredited laboratory. Certificate of conformity from Notified Body or accredited test house.
ISO 10993 (series)
Biological Evaluation		 65% Biocompatibility assessment for devices contacting patient tissue, blood, or body fluids. Required for Class IIa/IIb/III devices with patient contact. Biocompatibility evaluation report from accredited testing laboratory. Confirm scope covers all contacting materials.
ISO 9001:2015
General Quality Management		 82% General QMS standard. Often maintained alongside ISO 13485 for non-medical product lines or as foundational system. Does not replace ISO 13485 for medical devices. Certificate from accredited certification body. Verify at IAF CertSearch (iafcertsearch.org).

*Adoption rates among Polish medical device manufacturers with documented international sales. Source: OIGWM industry survey, PAIH medtech sector data 2025. Percentages represent manufacturers holding current, valid certification confirmed through public registries.

Frequently Asked Questions

Common questions from procurement managers and distributors about sourcing medical devices from Poland

ISO 13485:2016 certification for medical device quality management systems is issued by accredited third-party certification bodies (Notified Bodies or national accreditation body-approved CBs). Verification requires several parallel steps to confirm certificate authenticity, current validity, and scope coverage relevant to the products you intend to procure. First, request the original certificate from the supplier including certificate number, issuing body name, scope of certification (the scope statement must cover the specific device types and activities—design, manufacturing, sterilisation—relevant to your order), issue date, expiry date, and certification body contact details. Second, cross-reference the certificate number and scope directly with the issuing certification body. Major bodies active in Poland include TÜV SÜD, TÜV Rheinland, BSI Group, SGS, Bureau Veritas, DNV, LRQA, and Polish certification body PCBC (Polskie Centrum Badań i Certyfikacji). Each body maintains an online public register or will verify certificates upon request by telephone or email. Third, confirm the issuing certification body itself holds current accreditation for ISO 13485 certification from an IAF (International Accreditation Forum) member accreditation body—in Poland this is PCA (Polskie Centrum Akredytacji), accessible at pca.gov.pl, whose scope of accreditation listings confirm which CBs are authorised to issue ISO 13485 certificates. Fourth, for manufacturers placing devices on the EU market under Classes IIa, IIb, or III, a Notified Body certificate is additionally required under EU MDR 2017/745. Notified Body involvement (e.g., BSI 0086, TÜV SÜD 0123, SGS Belgium 1639) is publicly verifiable through the NANDO database at ec.europa.eu/growth/tools-databases/nando/ and the EUDAMED database at eudamed.ec.europa.eu once fully operational. For ongoing supply relationships, annual or biennial re-audit of supplier ISO 13485 status forms part of a standard Quality Agreement (QAA) and Approved Supplier List (ASL) maintenance programme. Surveillance audits by the CB occur annually, and certificate renewal requires full recertification audit every three years; confirm your supplier's next scheduled surveillance dates during the qualification process.

EU MDR 2017/745, fully applicable since May 2021 (with extended transition periods for legacy devices), establishes the legal framework for placing medical devices on the European Single Market. For international buyers sourcing from Polish manufacturers, MDR implications divide into two distinct scenarios depending on whether you are purchasing CE-marked finished goods for distribution under the manufacturer's name, or whether you intend to place the device on the market under your own brand (private label / re-labelling). In the first scenario—purchasing CE-marked devices for distribution in the EU under the Polish manufacturer's name and CE mark—your obligations as a distributor under MDR Article 14 include verifying that the device bears a valid CE mark with Notified Body identification number (for Class IIa/IIb/III), that the manufacturer is registered in EUDAMED, that a Declaration of Conformity (DoC) is available, that the device has a UDI (Unique Device Identification) label, and that the Instructions for Use (IFU) are in the official language(s) of the destination EU member states. Distributors must also implement a Quality Management System adequate for their distribution activities and report serious incidents and field safety corrective actions (FSCAs) to competent authorities. In the second scenario—private labelling under Article 16 MDR—you become an "economic operator" assuming responsibilities equivalent to a manufacturer. This requires registering as an economic operator in EUDAMED, preparing your own Declaration of Conformity, maintaining a post-market surveillance (PMS) system, and establishing a quality management system meeting ISO 13485:2016 requirements. The Polish OEM manufacturer must supply a "manufacturing agreement" acknowledging the arrangement and confirming their ISO 13485 QMS covers the Article 16 activities. Many established Polish medtech manufacturers have extensive experience with private-label programmes, including providing UDI assignments, label artwork review, regulatory file transfers, and ongoing technical support for Article 16 operators. Practical timelines for implementing an Article 16 private-label arrangement with an existing CE-marked Polish device range from four to ten weeks depending on labelling complexity, IFU translation requirements, and EUDAMED registration processing.

Polish medical device manufacturers typically price 15-30% above Chinese competitors on a unit ex-works basis for commodity items such as single-use consumables, basic surgical instruments, and hospital furniture. However, total-cost-of-ownership analysis consistently favours Polish sourcing across several dimensions that Chinese procurement does not address adequately for the European market. Regulatory compliance represents the most significant differentiating factor: Polish manufacturers operate within the EU regulatory framework (EU MDR 2017/745, ISO 13485:2016), meaning CE certificates, Technical Files, Declarations of Conformity, and EUDAMED registrations are managed under the same legal system as destination markets. Chinese manufacturers exporting to the EU must satisfy identical regulatory requirements but frequently lack the institutional understanding of EU competent authority expectations, harmonised standard interpretations, and Notified Body relationships that Polish manufacturers have cultivated over decades. Non-compliant CE marking from Chinese sources has been identified as a significant enforcement risk by EU market surveillance authorities (RAPEX system). Logistics and lead times constitute a second critical dimension: Polish manufacturers offer 1-3 day road freight delivery to German, Austrian, and Benelux markets with full cold-chain capability and ADR compliance for Class III sterile devices, versus 18-35 day sea freight from China with associated inventory carrying costs, quality inspection costs at port, and supply disruption risk. Communication and quality management integration represent additional advantages: Polish manufacturers engage in synchronous communication during CET business hours, participate in supplier development programmes, conduct on-site audits within a 1-2 hour flight distance, and implement Corrective and Preventive Action (CAPA) procedures within standard Western quality management frameworks. For European hospital procurement, Group Purchasing Organisations (GPOs), and distributors with regulatory obligations, Polish sourcing eliminates the supply chain risk premium associated with Far East procurement while delivering total cost outcomes 28-45% below German or Dutch manufacturing alternatives.

A Quality Agreement (QAA), sometimes called a Quality Technical Agreement or Supply Quality Agreement, is a binding document between a medical device buyer/distributor and a contract manufacturer that defines each party's quality management responsibilities and obligations. Under ISO 13485:2016 Section 7.4.3, documented agreements with external parties involved in supply chain activities are required, and EU MDR Annex IX explicitly requires technical documentation on manufacturing arrangements. A comprehensive QAA with a Polish manufacturer should address the following key areas: scope and product coverage (specific device types, part numbers, classification under EU MDR, and applicable regulatory territories covered by the agreement); quality system responsibilities (defining which party holds ISO 13485 scope for which activities, including design, manufacturing, sterilisation, labelling, distribution, and post-market surveillance); document control (procedures for Technical File maintenance, product specification updates, label changes, and IFU revisions, with clear notification and approval timelines); change control (mandatory prior notification and buyer approval required before any changes to materials, manufacturing processes, sub-suppliers, sterilisation providers, or production site that may affect device conformity); non-conformance and CAPA management (procedures for reporting product non-conformances, investigation timelines—typically 30 days for root cause analysis—CAPA implementation, and effectiveness verification); post-market surveillance (responsibilities for Periodic Safety Update Reports, Post-Market Clinical Follow-up, trend analysis, and customer complaint handling under MDR Article 87); audit rights (annual or biennial right to audit manufacturer premises, quality records, device history records, and corrective action logs, with provisions for unannounced audits in the event of quality events); recall and Field Safety Corrective Action (FSCA) procedures (notification timelines, recall execution responsibilities, batch traceability requirements, and authority notification procedures); and commercial terms interface (batch release criteria, Certificate of Conformance requirements, shelf-life guarantees, and claims procedures for non-conforming deliveries). Polish medtech manufacturers with established export programmes typically maintain standard QAA templates compatible with European and US procurement requirements, significantly reducing negotiation burden for new supply relationships.

Poland is an EU member state with intellectual property law fully harmonised with European frameworks, providing strong and internationally enforceable protection for medical device IP developed in contract manufacturing relationships. The legal basis for IP protection encompasses Polish Industrial Property Law (Prawo własności przemysłowej), the EU Trade Marks Regulation (EUTMR 2017/1001), EU Designs Regulation (2002/6/EC), the Directive on the Protection of Trade Secrets (2016/943), and the European Patent Convention. In practice, IP protection for custom medical device development with Polish OEMs operates through several contractual and technical mechanisms. Confidentiality Agreements (NDAs) should be executed before any technical disclosure, covering product concepts, clinical data, manufacturing processes, business plans, and customer information. For custom device development, NDAs should be bilateral, cover employees and sub-contractors of the Polish manufacturer, and specify a minimum five-year post-project confidentiality period appropriate for medical device development cycles. Design and Intellectual Property Assignment Agreements ensure that all IP developed during the project—including product designs, engineering drawings, manufacturing processes developed specifically for the project, software code, and validation data—is explicitly assigned to the commissioning party upon payment. Polish law recognises work-for-hire principles and IP assignment clauses are standard practice in professional medtech OEM contracts. Tooling and Equipment Ownership documentation (separate schedules listing all moulds, jigs, test equipment, and bespoke fixtures purchased for the project, with clear buyer ownership notation) protects against asset disputes in the event of relationship termination. Technical File and Regulatory Documentation Ownership clauses within the Quality Agreement ensure the buyer retains ownership of Technical Files, CE certificates, EUDAMED registrations, and clinical evaluation reports, even where the Polish manufacturer is listed as the legal manufacturer for MDR purposes. In practice, leading Polish medtech manufacturers with international OEM programmes have refined IP agreement frameworks through experience with major European and US device companies, and will typically accept IP terms consistent with EN/ISO industry standards and MDCG guidance. For highly sensitive proprietary technologies, additional measures available include split manufacturing (different components manufactured at separate facilities), clean-room data segregation policies, and formal audit rights for IP compliance.

Minimum order quantities and production lead times for Polish medical device manufacturers vary substantially by product category, device class, sterilisation requirements, and whether the buyer is placing repeat orders against established production tooling or initiating a new product programme. For standard, non-sterile Class I devices and equipment (hospital furniture, basic surgical instruments, rehabilitation aids, dental accessories), MOQs are typically 50-500 units depending on product complexity, with production lead times of 3-8 weeks for established product lines and 10-20 weeks for custom configurations requiring new tooling. For sterile single-use devices (Class IIa/IIb, requiring EtO or gamma sterilisation), MOQs are governed partly by sterilisation batch economics: typical minimum sterilisation batch sizes of 1,000-5,000 units translate to corresponding order quantities for sterile items, with lead times of 6-14 weeks including sterilisation cycle time and post-sterilisation quarantine (typically 4-6 weeks for EtO degassing and sterility testing). For Class IIa/IIb active devices (diagnostic equipment, electrosurgical units, physiotherapy apparatus), MOQs are lower (10-50 units) but lead times are longer (8-16 weeks) due to component procurement, subassembly lead times, calibration, and electrical safety testing (IEC 60601) requirements. For IVD reagents and test kits, MOQ is often expressed in kit equivalents (typically 500-2,000 test kits minimum) with lead times of 4-10 weeks, including lot release testing and shelf-life verification. Manufacturers with established international distribution relationships frequently offer blanket order programmes—annual quantity commitments with monthly call-off releases—that reduce effective lead times to 1-3 weeks from call-off, provide better pricing through volume commitment, and simplify procurement planning. Polish manufacturers generally demonstrate greater flexibility on MOQ and lead time negotiation than equivalent Western European manufacturers, particularly for buyers establishing first-time supply relationships with growth potential, and are experienced in managing European distributor requirements including small initial qualification orders followed by ramp-up schedules.

Free Download: Polish Medical Devices Sourcing Guide 2026

Practical procurement guide for hospital buyers, distributors, and medtech companies including:

  • ISO 13485 vendor qualification checklist
  • EU MDR / IVDR compliance verification
  • Quality Agreement (QAA) template
  • Price benchmarks by device category
  • Supplier audit framework
  • Top Polish medtech manufacturers list

Download Free Guide

We respect your privacy. No spam, unsubscribe anytime.

Medical Devices Product Categories

Explore Polish medical device manufacturing capabilities by product segment

Surgical Instruments

Precision surgical tools, laparoscopic instruments, OR equipment

View Products
Diagnostic Equipment

Imaging, laboratory analysers, point-of-care diagnostics

View Products
Rehabilitation Devices

Physiotherapy equipment, orthotics, prosthetics, mobility aids

View Products
Dental Equipment

Dental units, handpieces, implants, consumables

View Products
Hospital Furniture

Medical beds, trolleys, OR tables, patient care equipment

View Products
Wound Care & Single-Use

Dressings, sterile disposables, sutures, IV sets

View Products
In-Vitro Diagnostics (IVD)

Reagents, test kits, diagnostic strips, analysers

View Products
Healthcare IT & Software

Medical software (Class I SaMD), hospital information systems

View Products

Poland's Medical Devices Sector by Numbers

Source: OIGWM, PAIH Polish Medtech Report 2025, GUS Statistical Yearbook 2025

€2.3B

Annual Export Revenue

Medical devices (2025)

750+

Manufacturers

Export-certified firms

80+

Export Countries

Global buyer base

91%

ISO 13485 Certified

Export-oriented firms
Dla Polskich Producentów Wyrobów Medycznych

Dołącz do B2BPoland jako Zweryfikowany Producent Wyrobów Medycznych

Onboardujemy certyfikowane polskie firmy z branży wyrobów medycznych. Uzyskaj dostęp do międzynarodowych nabywców, dystrybutorów i szpitali poszukujących polskich producentów.

Co otrzymasz:
  • ✓ Profil z certyfikatami ISO 13485 / MDR
  • ✓ Leady od dystrybutorów i szpitali
  • ✓ Promocja w raportach branżowych
  • ✓ Widoczność dla buyers GPO
Wymagania:
  • ✓ Producent wyrobów medycznych w Polsce
  • ✓ Certyfikat ISO 13485:2016
  • ✓ Deklaracja Zgodności CE / EUDAMED
  • ✓ Doświadczenie w eksporcie

Zgłoś firmę do bazy

Skontaktujemy się w ciągu 48h

Get Early Access to the Medical Device Supplier Directory

Be first to access our curated database of ISO 13485-certified Polish medical device manufacturers, complete with EU MDR compliance status, device classification, and CE certificate details.

Why Source Medical Devices from Poland?

Regulatory Compliance

Polish manufacturers operate within EU regulatory frameworks (MDR 2017/745, IVDR 2017/746) with established Notified Body relationships. ISO 13485:2016 adopted by 91% of export firms. Full EUDAMED registration and CE marking compliance.

Cost Competitiveness

35-50% manufacturing cost advantage versus Germany and Netherlands with equivalent regulatory standing. Total landed cost savings of 28-42% after Central European freight costs. No customs barriers within EU Single Market.

Supply Chain Agility

1-3 day road freight to Germany, Austria, Benelux markets. GDP-compliant cold-chain capability. Short lead times enable JIT and Kanban supply programmes. Easy on-site audits within 1-2 hour flight distance from major European hubs.

Data Sources and References

Market intelligence presented on this page draws from authoritative Polish and European sources to provide accurate data for procurement professionals evaluating Polish medical device manufacturers.

Industry Associations
  • OIGWM (Ogólnopolska Izba Gospodarcza Wyrobów Medycznych) – Polish medical device industry association; market statistics, export data, regulatory updates. polishmedicaltechnology.com
  • KIG (Krajowa Izba Gospodarcza) – Polish Chamber of Commerce; general trade and export statistics. kig.pl
  • Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA – Pharma and medtech sector data. infarma.pl
  • POLMED (Polish Medical Technology Association) – Distributor and manufacturer representation, healthcare procurement data. polmed.com.pl
Government & Statistical Sources
  • GUS (Główny Urząd Statystyczny) – Official production and trade statistics for medical devices. stat.gov.pl
  • PAIH (Polska Agencja Inwestycji i Handlu) – Polish medtech sector investment and export reports. paih.gov.pl
  • PARP (Polska Agencja Rozwoju Przedsiębiorczości) – SME export data, innovation reports. parp.gov.pl
  • Urząd Rejestracji Produktów Leczniczych (URPL) – Polish competent authority for medical device market surveillance; registration data. urpl.gov.pl
EU Regulatory Frameworks
  • EU MDR 2017/745 – Medical Devices Regulation. eur-lex.europa.eu
  • EU IVDR 2017/746 – In Vitro Diagnostic Medical Devices Regulation. eur-lex.europa.eu
  • EUDAMED – European database on medical devices; manufacturer and device registration. eudamed.ec.europa.eu
  • NANDO Database – EU Notified Body information; certificate verification. ec.europa.eu/growth/tools-databases/nando/
International Standards
  • ISO 13485:2016 – Medical devices quality management systems.
  • ISO 14971:2019 – Application of risk management to medical devices.
  • IEC 60601-1:2005+AMD1+AMD2 – Medical electrical equipment, general requirements for safety.
  • IEC 62304:2006+AMD1:2015 – Medical device software lifecycle processes.
  • ISO 10993 series – Biological evaluation of medical devices.
  • EN ISO 11135 / 11137 – Sterilisation of health care products (EtO / radiation).
Technology Clusters & Research
  • Mazovieckie Centrum Innowacji w Medycynie (MCIM) – Warsaw-region medtech cluster. mcim.com.pl
  • Śląski Klaster Technologii Medycznych – Silesian Medical Technology Cluster, Katowice. klastermedyczny.pl
  • BioNanoPark Łódź – Medtech and biotech research park. bionanoparkp.pl
  • Wrocław Technology Park – Hosts medical device and diagnostics companies. wpt.pl
Primary Research
  • Manufacturer Surveys – Structured interviews with 38 Polish medical device manufacturers, Q3-Q4 2025, covering export volumes, pricing structures, certification status, production capabilities, and customer profile.
  • Buyer Interviews – Feedback from 22 European distributors and procurement managers sourcing from Poland on quality performance, lead times, regulatory support, and value assessment.
  • Price Benchmarking – Q4 2025 quotation analysis across 6 product categories, comparing Polish, German, and Dutch supplier quotations for standardised specifications.

Data Currency Notice: All market statistics reflect calendar year 2025 data. Price benchmarks represent Q4 2025 market conditions. Certification adoption rates verified through public registries as of February 2026. Regulatory framework references reflect legislation in force as of the publication date. Readers should verify current device registrations, certificate validity, and regulatory status directly through EUDAMED, NANDO, and URPL before making procurement decisions.

Disclaimer: The information presented on this page is provided for general market orientation purposes only and does not constitute professional regulatory, legal, or procurement advice. Medical device procurement decisions involve significant regulatory, clinical, and commercial risk. Buyers are responsible for conducting independent verification of supplier regulatory compliance including ISO 13485 certificate validity, EU MDR/IVDR conformity documentation, CE marking legitimacy, EUDAMED registration status, and Notified Body certificate scope. All quality agreements, supply contracts, intellectual property arrangements, and commercial terms should be reviewed by qualified regulatory affairs professionals and legal counsel familiar with EU medical device law. B2BPoland.com assumes no liability for procurement decisions, product non-conformances, regulatory violations, patient safety incidents, or commercial losses arising from reliance on information presented. Specific product pricing, lead times, MOQ, and availability data must be confirmed directly with individual manufacturers. B2BPoland.com does not endorse or warrant the regulatory compliance, product quality, or commercial reliability of any specific manufacturer. Market data reflects best available estimates from cited sources; actual market conditions may vary.

Ready to Source Medical Devices from Poland?

Connect with ISO 13485-certified Polish medical device manufacturers. Submit your RFQ or request the Medtech Sourcing Guide.

Submit RFQ

Quick Links

Home Companies Products Insights About Poland Resources Contact Us

Industries

Technology & Software Manufacturing & Industrial Healthcare & Medical Food & Beverages Cosmetics & Personal Care Automotive & Components Construction & Building Fashion & Textiles Energy & Environment

Contact Info

Dołącz do B2BPoland Legnica, Poland info@b2bpoland.com Mon - Fri 9:00 - 17:00 CET
B2BPoland.com, All right reserved.
Menu